Aptar Email Format

Packaging and Containers Manufacturing
10,001-25,000 employees
Crystal Lake, IL, USA

Aptar is a global leader in drug and consumer product dispensing, dosing, and protection technologies serving pharmaceutical, beauty, food, beverage, and personal care markets.

Find contacts at Aptar

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@aptar.com

Company Overview

Industry
Packaging and Containers Manufacturing
Headquarters
Crystal Lake, IL, USA
Revenue
$2.5B-$5B
FUNDING Stage
Public
Key Executives
Gael Touya (President and Chief Executive Officer), Vanessa Kanu (Executive Vice President, Chief Financial Officer), Antonio D'Alessandro (Vice President & Chief Information Officer)

Tech Stack

SAP S/4HANA

ERP

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Aptar?

Aptar uses the first.last format, so Jane Smith would be jane.smith@aptar.com.

What are Aptar's three main business segments?

Aptar operates through three business segments: Aptar Pharma, Aptar Beauty, and Aptar Closures. These segments serve markets ranging from pharmaceutical drug delivery to fragrance, skincare, food, and beverage dispensing solutions.

How many employees does Aptar have?

Aptar has approximately 7,840 employees worldwide. Tools like Clay can help you identify and reach the right Aptar contacts by role, team, or location when building a prospect list.

Who is the CEO of Aptar in 2026?

Gael Touya became President and Chief Executive Officer of Aptar effective September 1, 2026, succeeding Stephan Tanda who had led the company since 2017.

What drug delivery technologies is Aptar Pharma developing for GLP-1 therapies?

Aptar Pharma is advancing nasal and pulmonary delivery platforms for GLP-1 therapies, with new patent applications and preclinical data filed in 2026. The segment also supplies injectable components such as vial stoppers and pre-filled syringe plungers for GLP-1 drug manufacturers.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles